Valuation dashboard for UFP Technologies, Inc. (UFPT) with P/E 29.85, P/B 4.67, EV/EBITDA 19.84 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surg...
Analysis Summary
UFP Technologies, Inc. reported revenue of $602.8M in the most recent fiscal year, growing at a 5-year CAGR of 27.4%. Net income reached $68.3M, with a 38.6% 5-year CAGR.
Trailing-twelve-month margins: gross margin 28.5%, operating margin 15.2%, net margin 11.4%.
At the current price of $275.41, UFPT trades at a P/E of 29.85 and an ROE of 16.72%. Market capitalisation stands at $2.1B.
Balance sheet quality for UFPT: current ratio of 2.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 29.85 |
| Price / Book | 4.67 |
| EV / EBITDA | 19.84 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $222.26 |
| vs Current Price | -19.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| UFPT | UFP Technologies, Inc. | $2.2B | 29.85 | 4.67 | 16.7% |
| IMNM | Immunome, Inc. | $2.3B | 5.06 | -50.6% | |
| ESTA | Establishment Labs Holdings Inc. | $2.1B | 99.20 | -203.9% | |
| PGNY | Progyny, Inc. | $2.2B | 28.62 | 4.79 | 11.3% |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
Price
| Price | $275.41 |
| Market Cap | $2.1B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 16.72% |
| Return on Invested Capital | 12.65% |
| Return on Assets | 10.60% |
| Gross Margin | 28.50% |
| Operating Margin | 15.25% |
| Net Margin | 11.45% |
Related companies: AHCO · ALVO · CNMD · ESTA · IMNM · OMCL · PGNY
Explore sector: Healthcare · Medical - Devices
More sections of UFPT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks